Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NSE - Delayed Quote INR

Sakar Healthcare Limited (SAKAR.NS)

Compare
236.04
-6.20
(-2.56%)
At close: April 7 at 3:29:40 PM GMT+5:30

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Sanjay Surendra Shah Chairman & MD -- -- 1959
Mr. Dharmesh R. Thaker Chief Financial Officer -- -- --
Mr. Bharat S. Soni Company Secretary & Compliance Officer -- -- 1990

Sakar Healthcare Limited

406, Silver Oaks Comm. Complex
Opposite Arun Society Paldi
Ahmedabad, 380007
India
91 79 2658 4655 https://www.sakarhealthcare.com
Sector: 
Healthcare
Full Time Employees: 
325

Description

Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Corporate Governance

Sakar Healthcare Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 19, 2025 at 10:59 AM UTC - May 23, 2025 at 12:00 PM UTC

Sakar Healthcare Limited Earnings Date

Recent Events

Related Tickers

NATCAPSUQ.BO Natural Capsules Limited
188.00
-8.05%
 
AAREYDRUGS.NS Aarey Drugs & Pharmaceuticals Limited
45.28
-5.01%
 
GUFICBIO.NS Gufic Biosciences Limited
310.05
-5.59%
 
MEDICAMEQ.NS Medicamen Biotech Limited
458.15
-8.44%
 
WINDLAS.NS Windlas Biotech Limited
930.30
-5.40%
 
WANBURY.NS Wanbury Limited
242.11
-1.94%
 
ERIS.NS Eris Lifesciences Limited
1,274.65
-3.53%
 
RPGLIFE.NS RPG Life Sciences Limited
1,993.90
-8.36%
 
INNOVACAP.NS Innova Captab Limited
834.20
-4.26%
 
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
202.88
-6.00%